Get started
Author

Kristina Ellwanger

Observed name: Ellwanger, Kristina
OpenAlex ID: A5075328300
Loss of Dickkopf-1 Restores Neurogenesis in Old Age and Counteracts Cognitive Decline
2013 · Désirée R.M. Seib, Nina S. Corsini, et al. · Cell stem cell · 298
PDF
A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19 + tumor cells
2015 · Uwe Reusch, Johannes Duell, et al. · mAbs · 133
PDF
Targeted Disruption of the Wnt Regulator Kremen Induces Limb Defects and High Bone Density
2008 · Kristina Ellwanger, Hiroaki Saito, et al. · Molecular and Cellular Biology · 112
Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid Leukemia
2016 · Uwe Reusch, Kimberly H. Harrington, et al. · Clinical Cancer Research · 90
Preclinical evaluation of AFM24, a novel CD16A-specific innate immune cell engager targeting EGFR-positive tumors
2021 · Susanne Wingert, Uwe Reusch, et al. · mAbs · 70
Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity
2019 · Kristina Ellwanger, Uwe Reusch, et al. · mAbs · 66
PDF
Negative Regulation of Bone Formation by the Transmembrane Wnt Antagonist Kremen-2
2010 · Jochen Schulze, Sebastian Seitz, et al. · PLoS ONE · 63
PDF
Neural crests are actively precluded from the anterior neural fold by a novel inhibitory mechanism dependent on Dickkopf1 secreted by the prechordal mesoderm
2007 · Carlos Carmona-Fontaine, Gustavo Acuña, et al. · Developmental Biology · 63
Fate Specification of Neural Plate Border by Canonical Wnt Signaling and Grhl3 is Crucial for Neural Tube Closure
2015 · Chiharu Kimura-Yoshida, Kyoko Mochida, et al. · EBioMedicine · 58
PDF
Secreted Wnt antagonist Dickkopf-1 controls kidney papilla development coordinated by Wnt-7b signalling
2011 · Ilkka Pietilä, Kristina Ellwanger, et al. · Developmental Biology · 55
PDF
Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cells
2017 · Thorsten Gantke, Michael Weichel, et al. · Protein Engineering Design and Selection · 50
A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma
2022 · Satoko Kakiuchi-Kiyota, Thorsten Ross, et al. · Leukemia · 44
Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies
2017 · Kristina Ellwanger, Uwe Reusch, et al. · Frontiers in Oncology · 36
PDF
Preclinical Characterization of AFM26, a Novel B Cell Maturation Antigen (BCMA)-Directed Tetravalent Bispecific Antibody for High Affinity Retargeting of NK Cells Against Myeloma
2018 · Thorsten Ross, Uwe Reusch, et al. · Blood · 29
Dkk1 Regulates Ventral Midbrain Dopaminergic Differentiation and Morphogenesis
2011 · Diogo Ribeiro, Kristina Ellwanger, et al. · PLoS ONE · 25
PDF
Abstract 593: Highly cytotoxic EGFR/CD16A TandAbs specifically recruit NK cells to potently kill various types of solid tumors
2016 · Kristina Ellwanger, Uwe Reusch, et al. · Cancer Research · 24
AFM26 is a novel, highly potent BCMA/CD16A-directed bispecific antibody for high affinity NK-cell engagement in multiple myeloma.
2017 · Thorsten Gantke, Uwe Reusch, et al. · Journal of Clinical Oncology · 17
Cryopreservation of Natural Killer Cells Pre-Complexed with Innate Cell Engagers
2022 · Uwe Reusch, Kristina Ellwanger, et al. · Antibodies · 14
PDF
Trispecific Antibodies for Selective CD16A-Directed NK-Cell Engagement in Multiple Myeloma
2016 · Thorsten Gantke, Michael Weichel, et al. · Blood · 9
Selection of bispecific antibodies with optimal developability using FcRn‑pH‑HPLC as an optimized FcRn affinity chromatography method
2023 · Thomas Müller, Carolin Tasser, et al. · mAbs · 8
PDF
AFM26 - Targeting B Cell Maturation Antigen (BCMA) for NK Cell-Mediated Immunotherapy of Multiple Myeloma
2017 · Thorsten Gantke, Uwe Reusch, et al. · Blood · 7
Abstract 5659: AFM24, a bispecific EGFR/CD16A innate cell engager with the potential to overcome resistance to current targeted treatments for EGFR-positive malignancies
2020 · Uwe Reusch, Michael Damrat, et al. · Cancer Research · 6
Abstract 5671: AFM26 - A novel CD16A-directed bispecific TandAb targeting BCMA for multiple myeloma
2017 · Thorsten Gantke, Uwe Reusch, et al. · Cancer Research · 5
EGFR/CD16A tetravalent bispecific antibody AFM24 to engage NK-cells to kill EGFR expressing tumor cells and safety results in cynomolgus monkey studies.
2017 · Anne Kerber, Michael Kluge, et al. · Journal of Clinical Oncology · 4
Construction and characterization of novel CD33/CD3 tandem diabodies (TandAbs) for the treatment of acute myeloid leukemia (AML).
2015 · Uwe Reusch, Kimberly H. Harrington, et al. · Journal of Clinical Oncology · 3
Works count: 53
Citation count: 1,301
H-index: 17
I10-index: 18
Year
Topic
Type